Related Experiment Video
Updated: May 18, 2026
Intracranial Cannula Implantation for Serial Locoregional Chimeric Antigen Receptor (CAR) T Cell Infusions in Mice
Published on: February 24, 2023
Navigating cancer network attractors for tumor-specific therapy
Pau Creixell1, Erwin M Schoof, Janine T Erler
1Cellular Signal Integration Group (C-SIG), Center for Biological Sequence Analysis (CBS), Department of Systems Biology, Technical University of Denmark (DTU), Lyngby, Denmark.
Abstract:
Cells employ highly dynamic signaling networks to drive biological decision processes. Perturbations to these signaling networks may attract cells to new malignant signaling and phenotypic states, termed cancer network attractors, that result in cancer development. As different cancer cells reach these malignant states by accumulating different molecular alterations, uncovering these mechanisms represents a grand challenge in cancer biology. Addressing this challenge will require new systems-based strategies that capture the intrinsic properties of cancer signaling networks and provide deeper understanding of the processes by which genetic lesions perturb these networks and lead to disease phenotypes. Network biology will help circumvent fundamental obstacles in cancer treatment, such as drug resistance and metastasis, empowering personalized and tumor-specific cancer therapies.
Insights
Cancer cells shift to malignant states via network attractors, driven by molecular changes. Understanding these cancer network dynamics is key for developing targeted therapies against drug resistance and metastasis.
Area of Science:
- Systems biology
- Cancer biology
- Network science
Background:
- Cellular signaling networks are dynamic and crucial for biological decisions.
- Aberrant signaling networks can lead cells to malignant states (cancer network attractors).
- Diverse molecular alterations drive different cancer cells toward these malignant states.
Purpose of the Study:
- To explore systems-based strategies for understanding cancer signaling networks.
- To investigate how genetic lesions perturb networks and cause disease phenotypes.
- To identify mechanisms underlying cancer development and progression.
Main Methods:
- Analysis of dynamic cellular signaling networks.
- Systems-based approaches to model cancer network attractors.
- Investigating molecular alterations and their impact on network properties.
Main Results:
- Cancer development involves cells entering malignant signaling and phenotypic states.
- Uncovering the mechanisms of network perturbations in cancer is a significant challenge.
- Network biology offers insights into cancer complexity.
Conclusions:
- Systems-based strategies are needed to understand cancer signaling network perturbations.
- Network biology can reveal how genetic lesions drive cancer phenotypes.
- This approach can advance personalized and tumor-specific cancer therapies, overcoming drug resistance and metastasis.
Related Concept Videos
02:57Targeted Cancer Therapies
There are several types of targeted therapies against specific...
02:57Targeted Cancer Therapies
There are several types of targeted therapies against specific...
01:27Tumor Immunotherapy
02:53Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
02:50Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
02:49Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...